Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
2012 ◽
Vol 14
(11)
◽
pp. 990-999
◽
Keyword(s):
2015 ◽
Vol 6
(4)
◽
pp. 120-124
◽
Keyword(s):
2017 ◽
Vol 41
(5)
◽
pp. 377
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 68
(1)
◽
pp. 48-52
◽
Keyword(s):
2013 ◽
Vol 18
(5)
◽
pp. 811-818
◽
2009 ◽
Vol 12
(1)
◽
pp. 54-57
◽
Keyword(s):